{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:09:05Z","timestamp":1778494145728,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00210-024-03745-w","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T08:54:30Z","timestamp":1735030470000},"page":"7187-7198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-3602","authenticated-orcid":false,"given":"Zeynab","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4765-5218","authenticated-orcid":false,"given":"Ebrahim","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0629-9255","authenticated-orcid":false,"given":"Mitra Heydari","family":"Nasrabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8829-7715","authenticated-orcid":false,"given":"Masoud","family":"Salehipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"3745_CR1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00404-019-05111-1","volume":"299","author":"A Akbari Sene","year":"2019","unstructured":"Akbari Sene A, Tabatabaie A, Nikniaz H, Alizadeh A, Sheibani K, Mortezapour Alisaraie M, Tabatabaie M, Ashrafi M, Amjadi F (2019) The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial. Arch Gynecol Obstet 299:1701\u20131707","journal-title":"Arch Gynecol Obstet"},{"key":"3745_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09513590.2012.743020","volume":"29","author":"PG Artini","year":"2013","unstructured":"Artini PG, Di Berardino O, Papini F, Genazzani A, Simi G, Ruggiero M, Cela V (2013) Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecol Endocrinol 29:375\u2013379","journal-title":"Gynecol Endocrinol"},{"key":"3745_CR3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/17425255.2016.1206887","volume":"12","author":"M Bizzarri","year":"2016","unstructured":"Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A (2016) Pharmacodynamics and pharmacokinetics of inositol (s) in health and disease. Expert Opin Drug Metab Toxicol 12:1181\u20131196","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3745_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-022-00959-6","volume":"20","author":"A Bongrani","year":"2022","unstructured":"Bongrani A, Plotton I, Mellouk N, Ram\u00e9 C, Guerif F, Froment P, Dupont J (2022) High androgen concentrations in follicular fluid of polycystic ovary syndrome women. Reprod Biol Endocrinol 20:1\u201316","journal-title":"Reprod Biol Endocrinol"},{"key":"3745_CR5","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841\u20132855","journal-title":"Hum Reprod"},{"key":"3745_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejogrb.2011.07.038","volume":"159","author":"G Carlomagno","year":"2011","unstructured":"Carlomagno G, Nordio M, Chiu T, Unfer V (2011) Contribution of myo-inositol and melatonin to human reproduction. Eur J Obstet Gynecol Reprod Biol 159:267\u2013272","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3745_CR7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1096\/fj.05-4192fje","volume":"19","author":"JF Chau","year":"2005","unstructured":"Chau JF, Lee M, Law JW, Chung SK, Chung SS (2005) Sodium\/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J 19:1887\u20131889","journal-title":"FASEB J"},{"key":"3745_CR8","first-page":"509","volume":"15","author":"L Ciotta","year":"2011","unstructured":"Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F (2011) Effects of myo-inositol supplementation on oocyte\u2019s quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 15:509\u2013514","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3745_CR9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00404-013-2855-3","volume":"288","author":"S Colazingari","year":"2013","unstructured":"Colazingari S, Treglia M, Najjar R, Bevilacqua A (2013) The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Arch Gynecol Obstet 288:1405\u20131411","journal-title":"Arch Gynecol Obstet"},{"key":"3745_CR10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","volume":"94","author":"V Desforges-Bullet","year":"2010","unstructured":"Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S (2010) Increased anti-M\u00fcllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril 94:198\u2013204","journal-title":"Fertil Steril"},{"key":"3745_CR11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","volume":"443","author":"G Di Paolo","year":"2006","unstructured":"Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651\u2013657","journal-title":"Nature"},{"key":"3745_CR12","doi-asserted-by":"crossref","first-page":"1979654","DOI":"10.1155\/2016\/1979654","volume":"2016","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R (2016a) Inositol treatment and ART outcomes in women with PCOS. Int J Endocrinol 2016:1979654","journal-title":"Int J Endocrinol"},{"key":"3745_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R (2016b) The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online 33:15\u201328","journal-title":"Reprod Biomed Online"},{"key":"3745_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09513590801893232","volume":"24","author":"AD Genazzani","year":"2008","unstructured":"Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM (2008) Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 24:139\u2013144","journal-title":"Gynecol Endocrinol"},{"key":"3745_CR15","first-page":"e8079","volume":"12","author":"D Gupta","year":"2020","unstructured":"Gupta D, Khan S, Islam M, Malik BH, Rutkofsky IH (2020) Myo-inositol\u2019s role in assisted reproductive technology: evidence for improving the quality of oocytes and embryos in patients with polycystic ovary syndrome. Cureus 12:e8079","journal-title":"Cureus"},{"key":"3745_CR16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","volume":"34","author":"P Jin","year":"2018","unstructured":"Jin P, Xie Y (2018) Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol 34:272\u2013277","journal-title":"Gynecol Endocrinol"},{"key":"3745_CR17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.12891\/ceog4567.2019","volume":"46","author":"K Kitaya","year":"2019","unstructured":"Kitaya K, Takaya Y, Nishiyama R, Yamaguchi K, Matsubayashi H, Takeuchi T, Mizuta S, Ishikawa T (2019) Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study. Clin Exp Obstet Gynecol 46:549\u2013552","journal-title":"Clin Exp Obstet Gynecol"},{"key":"3745_CR18","first-page":"27","volume":"14","author":"M Kohzadi","year":"2020","unstructured":"Kohzadi M, Khazaei MR, Choobsaz F, Khazaei M (2020) Relationship between serum levels of anti-Mullerian hormone, adiponectin and oxidative stress markers in patients with polycystic ovary syndrome. Int J Fertil Steril 14:27","journal-title":"Int J Fertil Steril"},{"key":"3745_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00404-018-4861-y","volume":"298","author":"AS Lagana","year":"2018","unstructured":"Lagana AS, Vitagliano A, Noventa M, Ambrosini G, D\u2019Anna R (2018) Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet 298:675\u2013684","journal-title":"Arch Gynecol Obstet"},{"key":"3745_CR20","doi-asserted-by":"crossref","first-page":"4378507","DOI":"10.1155\/2016\/4378507","volume":"2016","author":"B Lesoine","year":"2016","unstructured":"Lesoine B, Regidor P-A (2016) Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. Int J Endocrinol 2016:4378507","journal-title":"Int J Endocrinol"},{"key":"3745_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10815-020-02014-y","volume":"38","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu Z, Zhao S, Cheng L, Man Y, Gao X, Zhao H (2021) Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. J Assist Reprod Genet 38:471\u2013477","journal-title":"J Assist Reprod Genet"},{"key":"3745_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1290.012","volume":"997","author":"N Macklon","year":"2003","unstructured":"Macklon N, Fauser B (2003) Mild stimulation in in vitro fertilization. Ann N Y Acad Sci 997:105\u2013111","journal-title":"Ann N Y Acad Sci"},{"key":"3745_CR23","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.fertnstert.2009.01.125","volume":"93","author":"R Mashiach","year":"2010","unstructured":"Mashiach R, Amit A, Hasson J, Amzalzg S, Almog B, Ben-Yosef D, Lessing JB, Limor R, Azem F (2010) Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril 93:2299\u20132302","journal-title":"Fertil Steril"},{"key":"3745_CR24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.rbmo.2017.07.005","volume":"35","author":"N Mendoza","year":"2017","unstructured":"Mendoza N, P\u00e9rez L, Simoncini T, Genazzani A (2017) Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Reprod Biomed Online 35:529\u2013535","journal-title":"Reprod Biomed Online"},{"key":"3745_CR25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11154-023-09819-z","volume":"24","author":"MV Moreira","year":"2023","unstructured":"Moreira MV, Vale-Fernandes E, Albergaria IC, Alves MG, Monteiro MP (2023) Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review. Rev Endocr Metab Dis 24:1045\u20131073","journal-title":"Rev Endocr Metab Dis"},{"key":"3745_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/life12020225","volume":"12","author":"J Nawrocka-Rutkowska","year":"2022","unstructured":"Nawrocka-Rutkowska J, Szyd\u0142owska I, Jakubowska K, Olszewska M, Chlubek D, Ry\u0142 A, Szczuko M, Starczewski A (2022) Assessment of the parameters of oxidative stress depending on the metabolic and anthropometric status indicators in women with PCOS. Life 12:225","journal-title":"Life"},{"key":"3745_CR27","doi-asserted-by":"crossref","first-page":"101698","DOI":"10.1016\/j.jogoh.2020.101698","volume":"49","author":"L Nazari","year":"2020","unstructured":"Nazari L, Salehpour S, Hosseini S, Saharkhiz N, Azizi E, Hashemi T, Ghodssi-Ghassemabadi R (2020) Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: a randomized controlled trial. J Gynecol Obstet Hum Reprod 49:101698","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"3745_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. The Lancet 370:685\u2013697","journal-title":"The Lancet"},{"key":"3745_CR29","doi-asserted-by":"crossref","unstructured":"Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S (2010) Interventions for \u2018poor responders\u2019 to controlled ovarian hyper stimulation (COH) in in\u2010vitro fertilisation (IVF). Cochrane Database Syst Rev 20:CD004379","DOI":"10.1002\/14651858.CD004379.pub3"},{"key":"3745_CR30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo E, Unfer V, Baillargeon J-P, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A (2007) Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 23:700\u2013703","journal-title":"Gynecol Endocrinol"},{"key":"3745_CR31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","volume":"91","author":"E Papaleo","year":"2009","unstructured":"Papaleo E, Unfer V, Baillargeon J-P, Fusi F, Occhi F, De Santis L (2009) Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril 91:1750\u20131754","journal-title":"Fertil Steril"},{"key":"3745_CR32","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","volume":"20","author":"T Piltonen","year":"2005","unstructured":"Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS (2005) Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20:1820\u20131826","journal-title":"Hum Reprod"},{"key":"3745_CR33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513590903366996","volume":"26","author":"E Raffone","year":"2010","unstructured":"Raffone E, Rizzo P, Benedetto V (2010) Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol 26:275\u2013280","journal-title":"Gynecol Endocrinol"},{"key":"3745_CR34","doi-asserted-by":"crossref","unstructured":"Regidor P-A, Schindler AE, Lesoine B, Druckman R (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Horm Mol Biol Clin Investig 34:20170067","DOI":"10.1515\/hmbci-2017-0067"},{"key":"3745_CR35","first-page":"19","volume":"81","author":"E Rotterdam","year":"2004","unstructured":"Rotterdam E (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","journal-title":"Fertil Steril"},{"key":"3745_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/REP-22-0152","volume":"164","author":"E Rudnicka","year":"2022","unstructured":"Rudnicka E, Duszewska AM, Kucharski M, Tyczy\u0144ski P, Smolarczyk R (2022) Oxidative stress and reproductive function: oxidative stress in polycystic ovary syndrome. Reproduction 164:145\u2013154","journal-title":"Reproduction"},{"key":"3745_CR37","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s10815-020-01956-7","volume":"37","author":"CR Sacha","year":"2020","unstructured":"Sacha CR, Chavarro JE, Williams PL, Ford J, Zhang L, Donahoe PK, Souter IC, Hauser R, P\u00e9pin D, M\u00ednguez-Alarc\u00f3n L (2020) Follicular fluid anti-M\u00fcllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center. J Assist Reprod Genet 37:2757\u20132766","journal-title":"J Assist Reprod Genet"},{"key":"3745_CR38","doi-asserted-by":"crossref","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2012) Insulin\u2010sensitising drugs (metformin, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 16:CD003053","DOI":"10.1002\/14651858.CD003053.pub5"},{"key":"3745_CR39","first-page":"452","volume":"15","author":"V Unfer","year":"2011","unstructured":"Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S (2011) Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci 15:452\u2013457","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3745_CR40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EC-17-0243","volume":"6","author":"V Unfer","year":"2017","unstructured":"Unfer V, Facchinetti F, Orr\u00f9 B, Giordani B, Nestler J (2017) Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect 6:647\u2013658","journal-title":"Endocr Connect"},{"key":"3745_CR41","doi-asserted-by":"crossref","first-page":"1849162","DOI":"10.1155\/2016\/1849162","volume":"2016","author":"V Unfer","year":"2016","unstructured":"Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F (2016) Effects of inositol (s) in women with PCOS: a systematic review of randomized controlled trials. Int J Endocrinol 2016:1849162","journal-title":"Int J Endocrinol"},{"key":"3745_CR42","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/biomedicines11061759","volume":"11","author":"V Unfer","year":"2023","unstructured":"Unfer V, Russo M, Aragona C, Bilotta G, Montanino Oliva M, Bizzarri M (2023) Treatment with myo-inositol does not improve the clinical features in all PCOS phenotypes. Biomedicines 11:1759","journal-title":"Biomedicines"},{"key":"3745_CR43","doi-asserted-by":"crossref","first-page":"6273298","DOI":"10.1155\/2016\/6273298","volume":"2016","author":"A Wdowiak","year":"2016","unstructured":"Wdowiak A (2016) Myoinositol improves embryo development in PCOS patients undergoing ICSI. Int J Endocrinol 2016:6273298","journal-title":"Int J Endocrinol"},{"key":"3745_CR44","volume-title":"Examination and processing of human semen","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Examination and processing of human semen. World Health, Geneva"},{"key":"3745_CR45","doi-asserted-by":"crossref","first-page":"e8842","DOI":"10.1097\/MD.0000000000008842","volume":"96","author":"X Zheng","year":"2017","unstructured":"Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y (2017) Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine 96:e8842","journal-title":"Medicine"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03745-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:48:17Z","timestamp":1748602097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3745"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03745-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Islamic Azad University, Varamin Pishva Branch (2021.08.28\/ IR.IAU.VARAMIN.REC.1400.033).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}